Skip to main content
. 2018 Jan 23;90(4):e342–e351. doi: 10.1212/WNL.0000000000004857

Figure 1. Risk of oral clefts in the exposed and reference groups.

Figure 1

Prevalence of oral clefts at birth (dots) and 95% confident intervals (lines) in infants after maternal exposure to topiramate and in the unexposed and lamotrigine-exposed reference groups. The topiramate-exposed group was further divided according to indication and, within monotherapy, by dose. Medicaid Analytic eXtract, 2000 to 2010.